Funder: Food and Drug Administration (FDA)
Due Dates: Projected: July 2025 (anticipated annual cycle)
Funding Amounts: Funding amounts vary; typical R01 awards support multi-year clinical trials.
Summary: Supports clinical trials evaluating efficacy and/or safety of products to address unmet needs in rare diseases or conditions.
Key Information: Forecasted opportunity; all dates and details subject to update.